SubHero Banner
Text

Xgeva® (denosumab) – New warning

January 24, 2018 - The FDA approved an update to the Warnings and Precautions section of the Xgeva (denosumab) drug label regarding multiple vertebral fractures (MVF) following treatment discontinuation.

Download PDF